147 related articles for article (PubMed ID: 29732412)
1. Insights into abnormal sphingolipid metabolism in multiple sclerosis: targeting ceramide biosynthesis as a unique therapeutic strategy.
Dasgupta S; Ray SK
Ther Targets Neurol Dis; 2017; 4():. PubMed ID: 29732412
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation.
Miller LG; Young JA; Ray SK; Wang G; Purohit S; Banik NL; Dasgupta S
Neurochem Res; 2017 Oct; 42(10):2755-2768. PubMed ID: 28474276
[TBL] [Abstract][Full Text] [Related]
3. Ceramide and Sphingosine Regulation of Myelinogenesis: Targeting Serine Palmitoyltransferase Using microRNA in Multiple Sclerosis.
Dasgupta S; Ray SK
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614447
[TBL] [Abstract][Full Text] [Related]
4. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
[TBL] [Abstract][Full Text] [Related]
5. Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.
Yue Y; Stanojlovic M; Lin Y; Karsenty G; Lin W
J Neuroinflammation; 2019 Feb; 16(1):23. PubMed ID: 30709400
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis.
Le Stunff H; Galve-Roperh I; Peterson C; Milstien S; Spiegel S
J Cell Biol; 2002 Sep; 158(6):1039-49. PubMed ID: 12235122
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipids in multiple sclerosis.
Jana A; Pahan K
Neuromolecular Med; 2010 Dec; 12(4):351-61. PubMed ID: 20607622
[TBL] [Abstract][Full Text] [Related]
8. Regulation of de novo sphingolipid biosynthesis by the ORMDL proteins and sphingosine kinase-1.
Siow D; Sunkara M; Morris A; Wattenberg B
Adv Biol Regul; 2015 Jan; 57():42-54. PubMed ID: 25319495
[TBL] [Abstract][Full Text] [Related]
9. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
10. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
11. Myriocin, a serine palmitoyltransferase inhibitor, alters regional brain neurotransmitter levels without concurrent inhibition of the brain sphingolipid biosynthesis in mice.
Osuchowski MF; Johnson VJ; He Q; Sharma RP
Toxicol Lett; 2004 Feb; 147(1):87-94. PubMed ID: 14700532
[TBL] [Abstract][Full Text] [Related]
12. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
13. Diverse Biological Functions of Sphingolipids in the CNS: Ceramide and Sphingosine Regulate Myelination in Developing Brain but Stimulate Demyelination during Pathogenesis of Multiple Sclerosis.
Dasgupta S; Ray SK
J Neurol Psychol; 2017 Dec; 5(1):. PubMed ID: 30338269
[TBL] [Abstract][Full Text] [Related]
14. Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures.
Grassi S; Giussani P; Prioni S; Button D; Cao J; Hakimi I; Sarmiere P; Srinivas M; Cabitta L; Sonnino S; Prinetti A
Neurochem Res; 2019 Jun; 44(6):1460-1474. PubMed ID: 30569280
[TBL] [Abstract][Full Text] [Related]
15. Absence of system x
Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
[TBL] [Abstract][Full Text] [Related]
17. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
[TBL] [Abstract][Full Text] [Related]
18. Myriocin treatment affects lipid metabolism in skeletal muscles of rats with streptozotocin-induced type 1 diabetes.
Kurek K; Garbowska M; Ziembicka DM; Łukaszuk B; Rogowski J; Chabowski A; Górski J; Żendzian-Piotrowska M
Adv Med Sci; 2017 Mar; 62(1):65-73. PubMed ID: 28189121
[TBL] [Abstract][Full Text] [Related]
19. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M
Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941
[TBL] [Abstract][Full Text] [Related]
20. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.
Yamamoto S; Yamashina K; Ishikawa M; Gotoh M; Yagishita S; Iwasa K; Maruyama K; Murakami-Murofushi K; Yoshikawa K
J Neuroinflammation; 2017 Jul; 14(1):142. PubMed ID: 28732510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]